Therapeutic effects of HIF-1α on bone formation around implants in diabetic mice using cell-penetrating DNA-binding protein

Sang Min Oh, Jin Su Shin, Il Koo Kim, Jung Ho Kim, Jae Seung Moon, Sang Kyou Lee, Jae Hoon Lee

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Patients with uncontrolled diabetes are susceptible to implant failure due to impaired bone metabolism. Hypoxia-inducible factor 1α (HIF-1α), a transcription factor that is up-regulated in response to reduced oxygen during bone repair, is known to mediate angiogenesis and osteogenesis. However, its function is inhibited under hyperglycemic conditions in diabetic patients. This study thus evaluates the effects of exogenous HIF-1α on bone formation around implants by applying HIF-1α to diabetic mice and normal mice via a protein transduction domain (PTD)-mediated DNA delivery system. Implants were placed in the both femurs of diabetic and normal mice. HIF-1α and placebo gels were injected to implant sites of the right and left femurs, respectively. We found that bone-to-implant contact (BIC) and bone volume (BV) were significantly greater in the HIF-1α treated group than placebo in diabetic mice (p < 0.05). Bioinformatic analysis showed that diabetic mice had 216 differentially expressed genes (DEGs) and 21 target genes. Among the target genes, NOS2, GPNMB, CCL2, CCL5, CXCL16, and TRIM63 were found to be associated with bone formation. Based on these results, we conclude that local administration of HIF-1α via PTD may boost bone formation around the implant and induce gene expression more favorable to bone formation in diabetic mice.

Original languageEnglish
Article number760
JournalMolecules
Volume24
Issue number4
DOIs
Publication statusPublished - 2019 Feb 20

Fingerprint

osteogenesis
Hypoxia-Inducible Factor 1
hypoxia
DNA-Binding Proteins
Therapeutic Uses
Osteogenesis
mice
Bone
deoxyribonucleic acid
proteins
bones
cells
Bone and Bones
genes
femur
Femur
Genes
Placebos
angiogenesis
Computational Biology

All Science Journal Classification (ASJC) codes

  • Analytical Chemistry
  • Chemistry (miscellaneous)
  • Molecular Medicine
  • Pharmaceutical Science
  • Drug Discovery
  • Physical and Theoretical Chemistry
  • Organic Chemistry

Cite this

Oh, Sang Min ; Shin, Jin Su ; Kim, Il Koo ; Kim, Jung Ho ; Moon, Jae Seung ; Lee, Sang Kyou ; Lee, Jae Hoon. / Therapeutic effects of HIF-1α on bone formation around implants in diabetic mice using cell-penetrating DNA-binding protein. In: Molecules. 2019 ; Vol. 24, No. 4.
@article{55c8626938fd496da78c8e83496359d5,
title = "Therapeutic effects of HIF-1α on bone formation around implants in diabetic mice using cell-penetrating DNA-binding protein",
abstract = "Patients with uncontrolled diabetes are susceptible to implant failure due to impaired bone metabolism. Hypoxia-inducible factor 1α (HIF-1α), a transcription factor that is up-regulated in response to reduced oxygen during bone repair, is known to mediate angiogenesis and osteogenesis. However, its function is inhibited under hyperglycemic conditions in diabetic patients. This study thus evaluates the effects of exogenous HIF-1α on bone formation around implants by applying HIF-1α to diabetic mice and normal mice via a protein transduction domain (PTD)-mediated DNA delivery system. Implants were placed in the both femurs of diabetic and normal mice. HIF-1α and placebo gels were injected to implant sites of the right and left femurs, respectively. We found that bone-to-implant contact (BIC) and bone volume (BV) were significantly greater in the HIF-1α treated group than placebo in diabetic mice (p < 0.05). Bioinformatic analysis showed that diabetic mice had 216 differentially expressed genes (DEGs) and 21 target genes. Among the target genes, NOS2, GPNMB, CCL2, CCL5, CXCL16, and TRIM63 were found to be associated with bone formation. Based on these results, we conclude that local administration of HIF-1α via PTD may boost bone formation around the implant and induce gene expression more favorable to bone formation in diabetic mice.",
author = "Oh, {Sang Min} and Shin, {Jin Su} and Kim, {Il Koo} and Kim, {Jung Ho} and Moon, {Jae Seung} and Lee, {Sang Kyou} and Lee, {Jae Hoon}",
year = "2019",
month = "2",
day = "20",
doi = "10.3390/molecules24040760",
language = "English",
volume = "24",
journal = "Molecules",
issn = "1420-3049",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "4",

}

Therapeutic effects of HIF-1α on bone formation around implants in diabetic mice using cell-penetrating DNA-binding protein. / Oh, Sang Min; Shin, Jin Su; Kim, Il Koo; Kim, Jung Ho; Moon, Jae Seung; Lee, Sang Kyou; Lee, Jae Hoon.

In: Molecules, Vol. 24, No. 4, 760, 20.02.2019.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Therapeutic effects of HIF-1α on bone formation around implants in diabetic mice using cell-penetrating DNA-binding protein

AU - Oh, Sang Min

AU - Shin, Jin Su

AU - Kim, Il Koo

AU - Kim, Jung Ho

AU - Moon, Jae Seung

AU - Lee, Sang Kyou

AU - Lee, Jae Hoon

PY - 2019/2/20

Y1 - 2019/2/20

N2 - Patients with uncontrolled diabetes are susceptible to implant failure due to impaired bone metabolism. Hypoxia-inducible factor 1α (HIF-1α), a transcription factor that is up-regulated in response to reduced oxygen during bone repair, is known to mediate angiogenesis and osteogenesis. However, its function is inhibited under hyperglycemic conditions in diabetic patients. This study thus evaluates the effects of exogenous HIF-1α on bone formation around implants by applying HIF-1α to diabetic mice and normal mice via a protein transduction domain (PTD)-mediated DNA delivery system. Implants were placed in the both femurs of diabetic and normal mice. HIF-1α and placebo gels were injected to implant sites of the right and left femurs, respectively. We found that bone-to-implant contact (BIC) and bone volume (BV) were significantly greater in the HIF-1α treated group than placebo in diabetic mice (p < 0.05). Bioinformatic analysis showed that diabetic mice had 216 differentially expressed genes (DEGs) and 21 target genes. Among the target genes, NOS2, GPNMB, CCL2, CCL5, CXCL16, and TRIM63 were found to be associated with bone formation. Based on these results, we conclude that local administration of HIF-1α via PTD may boost bone formation around the implant and induce gene expression more favorable to bone formation in diabetic mice.

AB - Patients with uncontrolled diabetes are susceptible to implant failure due to impaired bone metabolism. Hypoxia-inducible factor 1α (HIF-1α), a transcription factor that is up-regulated in response to reduced oxygen during bone repair, is known to mediate angiogenesis and osteogenesis. However, its function is inhibited under hyperglycemic conditions in diabetic patients. This study thus evaluates the effects of exogenous HIF-1α on bone formation around implants by applying HIF-1α to diabetic mice and normal mice via a protein transduction domain (PTD)-mediated DNA delivery system. Implants were placed in the both femurs of diabetic and normal mice. HIF-1α and placebo gels were injected to implant sites of the right and left femurs, respectively. We found that bone-to-implant contact (BIC) and bone volume (BV) were significantly greater in the HIF-1α treated group than placebo in diabetic mice (p < 0.05). Bioinformatic analysis showed that diabetic mice had 216 differentially expressed genes (DEGs) and 21 target genes. Among the target genes, NOS2, GPNMB, CCL2, CCL5, CXCL16, and TRIM63 were found to be associated with bone formation. Based on these results, we conclude that local administration of HIF-1α via PTD may boost bone formation around the implant and induce gene expression more favorable to bone formation in diabetic mice.

UR - http://www.scopus.com/inward/record.url?scp=85061906008&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061906008&partnerID=8YFLogxK

U2 - 10.3390/molecules24040760

DO - 10.3390/molecules24040760

M3 - Article

VL - 24

JO - Molecules

JF - Molecules

SN - 1420-3049

IS - 4

M1 - 760

ER -